Methyl-n-amylnitrosamine
| Names | |
|---|---|
| Preferred IUPAC name
 Methyl(pentyl)nitrous amide  | |
| Identifiers | |
3D model (JSmol) 
 | 
|
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| MeSH | N-amyl-N-methylnitrosamine | 
PubChem CID 
 | 
|
| UNII | |
CompTox Dashboard (EPA) 
 | 
|
  | |
  | |
| Properties | |
| C6H14N2O | |
| Molar mass | 130.191 g·mol−1 | 
| Appearance | Yellow, transparent liquid | 
| log P | 1.542 | 
| Related compounds | |
Related amines 
 | 
|
Related compounds 
 | 
Agmatine | 
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). 
Infobox references 
 | |
Methyl-n-amylnitrosamine (MNAN) is a potential carcinogen[1] It is metabolized in the liver by the enzyme CYP2A6.
References
- ^ Bulay O, Mirvish SS (September 1979). "Carcinogenesis in rat esophagus by intraperitoneal injection of different doses of methyl-n-amylnitrosamine". Cancer Res. 39 (9): 3644–6. PMID 476689.
 
